Pavel L Katsel, PhD
img_Pavel L Katsel
ASSOCIATE PROFESSOR | Psychiatry
Research

Dr. Katsel, since joining the Department of Psychiatry, has conducted research in the Division of Basic Science directed by Dr. Haroutunian. His primary areas of interest are the neurobiology of Alzheimer's disease and schizophrenia. Dr. Katsel applies molecular biological techniques to understand the biological substrates of schizophrenia and dementia. He is also a contributor to Mount Sinai's Silvio Conte Center for Neuroscience and the Alzheimer's Disease Research Center. Dr. Katsel's most recent publications focus on understanding molecular mechanism underlining the oligodendroglial and myelin deficits in schizophrenia as well as on sphingolipid metabolism abnormalities during the earliest stages of dementia and Alzheimer's disease.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Katsel has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.